Team Fortress 2’s annual Halloween celebration is here, and it’s got the works!
Articles by Aabicus
Dying is almost always a bad thing in Team Fortress 2 (indeed, most shooters). You aren’t helping your team while dead, you aren’t having fun while dead, and a good many unlocks are dedicated to keeping the player or his teammates alive. Trying not to die is, for the most part, a pretty good strategy and you’ll go far with it.
This is an editorial by Aabicus which analyses the successfulness of free-to-play games in the gaming industry with relation to Team Fortress 2. All views expressed here are his own.
The Free-to-play model is the current trend in multiplayer online games at the moment, most frequently seen in MMOs, MOBAs and shooters. Since several high-profile games (including Team Fortress 2) proved the model worked, the gaming industry have seen a staggering amount of F2P releases, some of whom keep their revenue-enhancing devices subtle and others who make real-world money the most valuable resource a player can have.
Which game developer would you most like to work for?
A recent survey by the Independent Game Developers Association reveals that most of the surveyed industry members picked Valve.
When the Sandman debuted during the Scout Update, Valve broke new ground regarding ranged melee weapons. Not since the Direct Hit has Team Fortress 2 been given a more spammable immediate-range weapon that crits like crazy, since the Sandman’s baseball shares the bat’s increased melee crit chance.
However, perhaps because of it’s unusual design, there have been a number of bizarre exploits associated with this weapon over the years and a few of these are still in the game today.
Minutes ago, a new post went up on the Team Fortress 2 blog, calling for T-Shirt designs for future merchandise. Enterprising artists are encouraged to upload their compositions to the Steam Workshop for all to see and vote on. Already there are over a dozen designs available to check out! My personal favorite is this shirt starring Archimedes.